BioPharma, Diagnostics How Genome Sequencing Can Broaden the Scope of Newborn Screening By Frank Vinluan
Health Tech How a pediatric hospital’s rare disease sequencing system is unlocking the whole genome By Katie Adams
MedCity Influencers, Diagnostics The power of Next Generation Sequencing in management of the pandemic and future outbreaks By Ramin Khaksar
BioPharma, Diagnostics PacBio’s $600M Omniome buyout brings together long & short of DNA sequencing By Frank Vinluan
BioPharma, Diagnostics Thermo Fisher, J&J partner on next-generation sequencing diagnostic for cancer clinical trials By Alaric DeArment
Diagnostics, Policy CMS to cover next-generation sequencing for inherited breast, ovarian cancers By Alaric DeArment
Daily, Hospitals, Diagnostics Helix, Mayo Clinic embark on genomic sequencing study of 100,000 people By Alaric DeArment
BioPharma, Diagnostics FDA green lights next-gen sequencing platform for drug-resistant HIV By Alaric DeArment
Diagnostics, Hospitals Thermo Fisher aims to make next-gen sequencing more accessible to community hospitals By Alaric DeArment
Diagnostics, Startups, Health Tech PierianDx raises $27M in Series B to ‘democratize’ next-generation sequencing By Alaric DeArment
Hospitals, Diagnostics Through partnership with Color, 10K NorthShore patients will get whole genome sequencing By Erin Dietsche
Payers, Diagnostics What ever happened to the NantHealth-Independence Blue Cross sequencing partnership? By Alaric DeArment
Diagnostics, Pharma Next-generation sequencing market to nearly triple in size by 2024, report says By Alaric DeArment
Diagnostics, BioPharma Strata Oncology scores $26 million for large-scale next-generation sequencing By Alaric DeArment
